A20 Regulation of Nuclear Factor–κB

Catriona Kelly, Michael D. Shields, J. Stuart Elborn, Bettina C. Schock
2011 American Journal of Respiratory Cell and Molecular Biology  
Persistent activation of NF-kB is central to the pathogenesis of many inflammatory lung disorders, including cystic fibrosis, asthma, and chronic obstructive pulmonary disease. A20 is an endogenous negative regulator of NF-kB signaling, which has been widely described in autoimmune and inflammatory disorders, including diabetes and Crohn's disease, but which has received little attention in terms of chronic lung disorders. This review examines the existing body of research on A20 regulation of
more » ... A20 regulation of NF-kB signaling and details the mechanism and regulation of A20 action focusing, where possible, on pulmonary inflammation. A20 and its associated signaling molecules are highlighted as being of potential therapeutic interest for the treatment of inflammatory disorders, and a proposed model of A20 activity in inflammatory lung disease is provided.
doi:10.1165/rcmb.2010-0339tr pmid:21239605 fatcat:6yn6qejszrf5daj2spymrl2uve